Articles

U01 Multi-Site Study Related Publications

Stock, P.G., et al., Outcomes of kidney transplantation in HIV-infected recipients.
N Engl J Med, 2010. 363(21): p. 2004-14.

Virologic and Clinical outcomes of hepatitis B virus infection in HIV-HBV coinfected transplant recipients.
Coffin CD, Stock PG, Dove LM, et al. Am J Transplant 2010;10:1268-75

Liver and Kidney Transplantation in HIV-infected Patients.
AIDS Review, 2009;11:190-204.

Renal transplantation in patients with HIV.
Frassetto, L. A., C. Tan-Tam, et al. (2009). Nat Rev Nephrol 5(10): 582-9.

MELD is an Important Predictor of Pre-Transplant Mortality in HIV-Infected Liver Transplant Candidates.
Aruna Subramanian, Margaret Ragni et al., Gastroenterology, Ms. No. GASTRO-D-09-00631R2

Treatment-dependent Loss of Polyfunctional CD8+ T-cell Responses in HIV-infected Kidney Transplant
Recipients Is Associated with Herpesvirus Reactivation.
Gasser, O., et al., Am J Transplant, 2009: 9; 1-10. PMCID: PMC2746278

Immunosuppressant pharmacokinetics and dosing modifications in HIV-1 infected liver and kidney
transplant recipients.
Frassetto LA, Benet LZ, et al. Am J Transplant. 2007 Dec;7(12):2816-20.

Evolving clinical strategies for transplantation in the HIV-positive recipient.
Stock, P. G. and M. E. Roland (2007). Transplantation 84(5): 563-71.

Solid Organ Transplantation: Referral, Management, and Outcomes in HIV-infected Patients.
Roland M, Carlson L, Frassetto L, Stock P, AIDS Reader 16 (12) 2006: 664-668.

Solid Organ Transplantation is a Reality for Patients with HIV Infection.
Roland, M.E. and P.G. Stock, Curr HIV/AIDS Rep, 2006. 3(3): p. 132-8.

Thymoglobulin-associated Cd4+ T-cell depletion and infection risk in HIV-infected renal transplant
recipients. Carter, J.T., et al., Am J Transplant, 2006. 6(4): p. 753-60.

Outcome of Patients with Hepatitis B Virus and Human Immunodeficiency Virus Infections Referred
for Liver Transplantation. Terrault NA, Carter JT, Carlson L, Roland ME, Stock PG. Liver Transplantation,
12:801-807, 2006

Liver transplantation in HIV-infected recipients.
Roland, M.E. and P.G. Stock, Semin Liver Dis, 2006. 26(3): p. 273-84.

Cyclosporine pharmacokinetics and dosing modifications in human immunodeficiency virus-
infected liver and kidney transplant recipients.
Frassetto, L., et al., Transplantation, 2005. 80(1): p. 13-7

Simultaneous assessment of cytotoxic T lymphocyte responses against multiple viral infections by combined
usage of optimal epitope matrices, anti-CD3 mAb T cell expansion and RecycleSpot.
Bihl F, Loggi E, Chisholm J, Henry L, Frahm N, Andreone P, Brander C., Journal Transl. Medicine. 2005; 11:20-31.

Pilot Study Related Publications

HIV-infected liver and kidney transplant recipients: 1- and 3-year outcomes.
Roland, M.E., Stock, P.G et al., Am J Transplant, 2008. 8(2): p. 355-65.

Kidney and liver transplantation in human immunodeficiency virus-infected patients: a pilot safety
and efficacy study. Stock, P. G., M. E. Roland, et al. (2003). Transplantation 76(2): 370-5.

Key clinical, ethical, and policy issues in the evaluation of the safety and effectiveness of solid
organ transplantation in HIV-infected patients.
Roland, M. E., B. Lo, et al. (2003). Arch Intern Med 163(15): 1773-8.

Review of solid-organ transplantation in HIV-infected patients.
Roland, M. E. and P. G. Stock (2003). Transplantation 75(4): 425-9.

Rapid Deterioration of HIV Co-infected Patients Waiting for Liver Transplantation Is Not Predicted
by MELD, Peter G. Stock, Liver Transplantation; November 2005

Responding to organ failure in HIV-infected patients.
Roland, M. E. and D. V. Havlir (2003). N Engl J Med 348(23): 2279-81.

Kidney and liver transplantation in HIV-infected patients: case presentations and review.
Roland, M. E., D. Adey, et al. (2003). AIDS Patient Care STDS 17(10): 501-7.

HIV and Transplant Related Publications

Co mprehensive guidelines translate research findings into clinical policy for HIV-infected transplant
candidates and recipients.
Roland, M. E. and P. G. Stock (2005). Enferm Infecc Microbiol Clin 23(6): 331-334.

GESIDA/GESITRA-SEIMC, PNS and ONT Consensus Document on Solid Organ Transplant (SOT) in
HIV-Infected Patients in Spain (March, 2005).
Miro, J. M., J. Torre-Cisnero, et al. (2005). Enferm Infecc Microbiol Clin 23(6): 353-62.

Solid-organ transplantation in HIV-infected patients.
Halpern, S. D., P. A. Ubel, et al. (2002). N Engl J Med 347(4): 284-7.

Safety and success of kidney transplantation and concomitant immunosuppression in HIV-positive
patients. Kumar, M. S., D. R. Sierka, et al. (2005). Kidney Int 67(4): 1622-9.

Human immunodeficiency virus infection and kidney transplantation in the era of highly active
antiretroviral therapy and modern immunosuppression. Abbott, K. C., S. J. Swanson, et al. (2004).
J Am Soc Nephrol 15(6): 1633-9.

Orthotopic liver transplantation in patients with human immunodeficiency virus and end-stage
liver disease. Neff, G. W., A. Bonham, et al. (2003). Liver Transpl 9(3): 239-47.

Survival of human immunodeficiency virus-infected liver transplant recipients.
Ragni, M. V., S. H. Belle, et al. (2003). J Infect Dis 188(10): 1412-20.
tommysfloorcovering.com